Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
168 studies found for:    new onset type 1 diabetes
Show Display Options
Download search resultsDownload the search results for:
new onset type 1 diabetes (168 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Albiglutide weekly injection;   Biological: Placebo weekly injection;   Biological: Insulin
2 Active, not recruiting Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Condition: New Onset Type-1 Diabetes
Interventions: Biological: Alpha-1 Antitrypsin;   Other: Placebo
3 Completed Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: Placebo control
4 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Condition: Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
5 Active, not recruiting Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: 180 mg/kg Alpha1-PI;   Biological: 90 mg/kg Alpha1-PI;   Biological: Placebo
6 Recruiting Immune Profile in Subjects With New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Inguinal lymph node fine needle aspirate biopsy;   Procedure: Inguinal lymph node core biopsy;   Procedure: Peripheral blood collection;   Other: Pre- and post-biopsy questionnaire
7 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
8 Terminated
Has Results
Inducing Remission in Type 1 Diabetes With Alefacept
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Biological: Alefacept;   Drug: Placebo
9 Completed A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: NBI-6024
10 Recruiting A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Drug: Ladarixin;   Drug: Placebo
11 Active, not recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Granulocyte colony stimulating factor (GCSF);   Drug: Placebo (for ATG);   Drug: Placebo (for GCSF)
12 Not yet recruiting Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric New-onset Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Diabetic Ketoacidosis
Interventions: Drug: Glargine;   Drug: IV insulin;   Other: Electrolyte Correction;   Other: Correction of Fluid Loss
13 Completed Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: 1,25-dihydroxy-vitamin D3 (calcitriol);   Drug: placebo
14 Terminated
Has Results
Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
15 Completed Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: immunosuppression and stem cell transplantation
16 Completed Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Telehomecare (Intelligent Distance Patient Monitoring);   Other: Standard education and follow up at diabetes clinic
17 Withdrawn Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: efalizumab;   Drug: placebo
18 Terminated
Has Results
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diabetes
Interventions: Drug: Insulin;   Drug: Lansoprazole;   Drug: Sitagliptin;   Biological: Diamyd;   Drug: GAD65 (Diamyd)
19 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
20 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.